| 标题 |
Five‐year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non‐small‐cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE ‐042 China study |
| 网址 | |
| DOI | |
| 其它 |
期刊:International Journal of Cancer 作者:Yi‐Long Wu; Li Zhang; Yun Fan; JianYing Zhou; Li Zhang; et al 出版日期:2025-12-31 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)